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Conclusions: Despite normal ECG, repolarisation abnormalities predisposing to arrhyth- 
mias might exist in asymptomatic relatives of ARVC patients. 
1207-84 Are Right Ventricular Wall Motion Abnormalities 
Reliable for the Diagnosis of Arrhythmogenic Right 
Ventricular Cardiomyopathy? A Cardiac Magnetic 
Resonance Imaging Study in Healthy Subjects Using a 
New Segmental Model 
Burkhard Sievers, Ulrich Franken, Marvin Addo, Asli Bakan, Simon Kirchberg. Hans- 
Joachim Trappe, University of Bochum. Heme, Germany 
Aims: To evaluate right ventricular wall motion abnormalities in healthy individuals using 
a new segmental model for the right ventricle. 
Methods and results: 29 healthy individuals (9 female, 20 male, mean age 48.9+15 
years) underwent magnetic resonance imaging (1.5 Tesla MRI Sonata, Siemens, Erlan- 
gen, Germany) to evaluate cardiac function and identify possible right ventricular wall 
motion abnormalities. TrueFlSP gradient-echo sequences with steady-state free preces- 
sion were used for image acquisition. Right ventricular wall motion abnormalities were 
analysed and classified according to a segmental model for the right ventricle. In 27 
(93.1%) of the 29 individuals right ventricular wall motion abnormalities were found. Dys- 
kin&a was found in 22 (75.9%). hypoklnesia in 11 (37.9%) and bulging in eight individu- 
als (27.6%). The number of diagnosed wall motion abnormalities in the transverse plane 
(86.2%) was significantly higher compared to those found in the short axis plane (13.8%) 
or in the horizontal longitudinal plane (41.4%) (p=O.OOO). 
Conclusion: 
Right ventricular wall abnormalities can be found in healthy individuals. Since these wall 
abnormalities are a criterion for the diagnosis of arrhythmogenic right ventricular cardi- 
omyopathy, wall motion abnormalities around the insertton of the muscular ligaments of 
the right ventricle should be excluded to prevent an incorrectly positive diagnosis. 
1207-85 Diastolic Dysfunction After Neurocardiogenic Injury: 
Prevalence and Association With Pulmonary Edema 
Alexander Kopelnik. Payee P. Tung. Nader M. Banki, Michael T. Lawton. Daryl Gress. 
Barbara J. Drew, Elyse Foster, William W. Parmley, Jonathan G. Zaroff, UCSF, San 
Francisco, CA 
Introduction: ECG changes, troponin release, and reduced left ventricular ejection frac- 
tion (LVEF) have been described after subarachnoid hemorrhage (SAH) Little is known 
about the occurrence of diastolic dysfunction in this patient population. We aimed to 
determine the prevalence of diastolic dysfunction and its association with cardiac out- 
comes after SAH. 
Methods: Over a period of 2 years, echocardiographic, clinical, chest X-ray, and cardiac 
troponin I (cTi) data was obtained on day 1, 3, and 6 following enrollment I” consecutive 
SAH patients admitted to UCSF medical center. Each echocardiogram included Doppler 
recordings of mitral inflow (earfy[E] and atrral contraction[A] velocities, E wave decelera- 
tion tlme[DTp and pulmonary venous flow (systoltc[S] and diastolic[D] velocities). For 
each study, diastolic function was categorized as normal (E/A>l, S/D>l), impaired relax- 
ation (EIAcl. S/D>l), pseudonormal (E/A>l. S/D<l, DT>l50, age>40). or restrictive (E/ 
A>l, S/D<l, DT<l50, age>40). Subjects under 40 were included in the pseudonormal or 
restrictive groups if E/A>2 or SIDc0.4. LVEF was calculated by a blinded observer. Car- 
diac outcomes were treated as dichotomous variables: pulmonary edema by CXR (no or 
yes), LVEF p50% or <50%), and cTi (f .O or >l .O ug/L). 
Results: The study included 173 subjects, 154 had technically adequate Doppler data. 
Diastolic dysfunction was observed on at least one echocardiogram in 68% of subjects. 
The prevalence of diastolic vs. systolic dysfunction in 25 patients with pulmonary edema 
was 84% vs 36% respectively (p=O.OOl by chi square). A history of hypertension was slg- 
nificantly associated with all three categories of diastolic dysfunction. The restrictive pat- 
tern was associated with the following endpoints (by logistic regression): pulmonary 
edema (odds ratio [OR] 7.5; 95% confidence intervals [Cl] 1.83 - 40.4; pcO.015); reduced 
LVEF (OR 12.9; 95% Cl 2.68 61.87; p<O.OOl) and troponin release (OR 8.6; 95% Cl 
2.01 40.21; pcO.008). 
Conclusions: Diastolic dysfunction is c~mrn~n I” patients with SAH. It is associated with 
adverse cardiac outcomes and may explain the development of pulmonary edema in 
some SAH patients. 
1207-86 impact of Alpha-Tocopherol on the Hypertrophied Heart 
in a Murine Model of Systemic Carnitine Deficiency: The 
Involvement of 1 ,P-Diacylglycerol 
Rvotaro Takahashi, Toru Asai. Kenichiro Matsubara, Yoshihiro Saburi, Hideo Matsui, 
Kenji Okumura, Nagoya University Graduate School of Medicine, Nagoya, Japan 
Background: The juvenile visceral steatosls (JVS) mouse, a murine model of systemic 
carnitine deficiency, shows disorder of fatty acid oxidation and develops cardiac hyper- 
trophy associated with lipid accumulation. Recently, inhibitory effect of alpha-tocopherol 
(AT) on 1,2-diacylglycerol (DAG), which is independent of its antloxidant properties, has 
been reported. We investigated the involvement of DAG in cardiac hypertrophy due to 
fatty acid oxidation disorder by evaluating the effect of AT administration on the hearts of 
JVS mice. 
Methods: Both JVS and control mice were fed a high AT diet or a standard diet from 4 to 
8 weeks of age. Myocardial DAG level and its fatty acid composition were assessed at 8 
weeks of age. 
Results: The ventricular to body weight ratio in the JVS mice was significantly higher 
than that I” the control mice (11.2 versus 3.8 mug, P<O.Ol). and was reduced by AT 
treatment (9.7 mg/g, PcO.05 ver?.us JVS mice). Morphological analysis showed signifi- 
cantly increased ventricular wall thickness and myocyte width in the JVS mice compared 
with those in the control mice (P<O.Ol). AT treatment also significantly reduced them. In 
contrast, echocardiographic analysis showed deterioration of fractional shortening and 
exaggeration of left ventricular dilatation in the AT treated JVS mice (P<O.Ol versus JVS 
mice). The myocardial thiobarbituric acid-reactive substance level, an index of oxidative 
stress, was not affected by AT treatment. The myocardial DAG level was 2.5-fold higher 
in the JVS mice (2004 versus 806 ng/ventricular weight, P<O.Ol) with a significant 
increase in fatty acids of 18:l and 18:2 compared with that in the control mice. AT treat- 
ment reduced the myocardial DAG level in the JVS mice (1443 nglventricular weight, 
PcO.01 versus JVS mice) without any alteration of fatty acid composition. 
Conclusions: AT treatment may partially reduce the cardiac hypertrophy but deteriorate 
the cardiac contractile function of JVS mice through the inhibitory effect on DAG. An 
increase in DAG level might be involved in the development of cardiac hypertrophy and 
in the maintenance of cardiac function in hearts with fatty acid oxidation disorder. 
1207-87 Cardiovascular Manifestations in Females With 
Anderson-Fabry Disease 
Bhavesh Sachdev, Linda Richfield, Rajesh Thaman, Sami Firoozi, Juan Gimeno, Atul 
Mehta, Perry M. Elliott, St Georges Hospital Medical School, London, United Kingdom, 
Royal Free Hospital, RF and UCL School of Medicine, London, United Kingdom 
Aims: Anderson-Fabry disease (AFD) is an X-linked recessive disorder. Recent data 
have shown that cardiac involvement in males is common, however, the prevalence of 
cardiovascular abnormalities I” females is uncertain. The aim of this study was to charac- 
terise the cardiac structure and function in female patients referred for family screening 
or for cardiac assessment. 
Methods: Fifteen female heterozygotes (mean age 53.3 * 14.9 years, range 24-81) were 
identified either by mutational analysis or plasma a-galactosidase A (a-Gal) activity 
(mean 3.8 nmol/hr/ml r 1 .19, range 1.6.6.6nmollhr/ml). All patients had an ECG and 2-D 
transthoracic echocardlography. Twelve patients were able to perform maximal cardiop- 
ulmonary exercise testing. 
Results: Eleven of the 15 patients presented 240 years (mean 55 years * 11.14, range 
40-78) with cardiac symptoms. Four patients had hypertension. Thirteen patients had 
abnormal ECG’s: short PR interval (n=2). Romhilt-Estes criteria for left ventricular hyper- 
trophy (n=5) and T wave changes (n=l3). Left ventricular cavity dimensions and aortic 
root diameters were normal in all Datients. Eleven Datients had valvular abnormalities; 11 
patients had an increased left ventricular mass index C>l10glm2) mean 133.39/m’ + 
37.88, range 96-2459/m’; 4 patients had septal hypertrophy (18.8mm * 5.62, range 13. 
26mm). On transmitral Doppler, 5 patients had impaired relaxation with a reversal of their 
E/A ratio, and 1 patient had a restrictive left ventricular Doppler filling pattern. One patient 
had a low peak oxygen consumption < 80% predicted on metabolic exercise testing. 
Conclusion: This study suggests that cardiac involvement in females with Anderson- 
Fabry disease may be more c~mrn~n than previously reported. 
1207-88 Presentation and Outcomes of Left Ventricular 
Noncompaction in Children 
Marina L. Huahes, James L. Wilkinson, Robert G. Welntraub, Royal Children’s Hospital, 
Melbourne, Australia 
Background: Better imaging modalities are contributing to increased awareness of left 
ventricular non-compacbon (LVNC), but the significance of the diagnosis is often uncer- 
tain. This study describes our experience of LVNC in paediatric patients seen at the 
Royal Children’s Hospital, Melbourne, the sole paediatric cardiology service for a popula- 
tion of 4 million. 
Method: LVNC was diagnosed when prominent trabeculation of the LV involved greater 
than 50% of the myocardial wall on a short axis view (echocardlography or angiography). 
The clinical charts of all children exhibiting this characteristic myocardial anomaly were 
reviewed. Children referred for cardiac transplantation were excluded to avoid bias in the 
survival analysis 
Results 54 children fined the diagnostic criteria. 22 (13 male) had Isolated LVNC and 32 
(13 male) had LVNC associated with other congenital cardiac malformations 
(LVNC+CHD). These included hypoplastic right heart syndromes. atrial or ventricular 
septal defects, tetralogy or pulmonary atresia with VSD, truncus arteriosus and left heart 
obstructive lesions. Children with isolated LVNC presented later (5 months vs 2 days, 
p<O.OOl), were more likely to present with congestive cardiac failure (13/22 vs 8132, 
p<O.Ol), and less likely to survive to five years of age (58% vs 88%. p<O.Ol) than those 
with LVNC+CHD. Death was sudden or unexpected in four patients and a result of pro- 
gressive congestive failure I” nine. A defibrillator was indicated for ventricular arrhyth- 
mias in one patient with isolated LVNC. LV systolic dysfunction or restrictive physiology 
was more common among survivors with isolated LVNC (IO/l4 vs 6127, pcO.001). 
Conclusion: Isolated LVNC is associated with htgher mortality and worse long-term out- 
come than LVNC+CHD. Prospective studies may further illuminate the natural history of 
this unusual cardiomyopathy. 
